Yakup Ergün: A drug that neither prolongs life nor improves quality of life is not considered successful

Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X:

” Each paragraph can be addressed with counterarguments individually. However, collectively, I would say the following: I do not agree with the authors’ views.

A drug that neither prolongs life nor improves quality of life is not considered successful. If the confirmatory trial yields negative results, the accelerated approval should be withdrawn.”

Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug

Authors: Gautam U. Mehta and Richard Pazdur.

Source: Yakup Ergün/X